Psychologist, Assistant Professor
Psychology
Department: Psychiatry
As a psychologist, I specialize in the development, delivery, and dissemination of specialized clinical interventions for anxiety disorders and post traumatic stress disorder (PTSD). My goal is to work with clients to decrease suffering and enhance well-being. I provide empirically supported psychotherapies, including cognitive behavioral therapy, acceptance and commitment therapy, and exposure-based treatments such as exposure and response prevention (ERP) for obsessive-compulsive disorder and prolonged exposure (PE) for PTSD.
I work with adults of all ages. I take a warm, collaborative, and integrative approach that is informed by evidence-based treatments. I am a culturally oriented therapist and strive to do anti-racist and LGBTQIA+ positive work.
While not at work, I enjoy spending time with my family, hiking with my dog, and meditating.
Please note: Not all physicians schedule patients at each listed location.
I am an assistant professor in the Department of Psychiatry and Behavioral Health at The Ohio State University College of Medicine. My research focuses on post-traumatic stress disorder (PTSD), anxiety, suicide prevention and neuroimaging, with an emphasis on understanding the psychological and neural mechanisms that shape mental health outcomes.
My research program focuses on elucidating neurobehavioral mechanisms underlying trauma-related psychopathology and suicide risk. I integrate clinical neuroscience, behavioral science and clinical trial methodologies to better understand how trauma impacts emotion, cognition and decision-making and how these processes contribute to psychiatric disorders.
My current work uses clinical trials to improve existing evidence-based interventions for PTSD and suicide risk, particularly among military personnel and veterans. This includes evaluating brief, scalable cognitive-behavioral interventions such as cognitive processing therapy and crisis response planning, as well as novel augmentation strategies designed to enhance treatment response and reduce suicidal ideation. My research has also examined innovative approaches such as combining stellate ganglion block with psychotherapy to accelerate symptom improvement.
Collectively, these efforts are embedded within translational research programs that seek to bridge neurobiological mechanisms with real-world clinical applications. In addition to intervention research, I study neural systems involved in uncertainty, threat processing and reward processing, including the role of the ventromedial prefrontal cortex in emotional regulation, decision-making and psychopathology.
The overarching goal of my research program is to develop a mechanistic, neuroscience-informed model of trauma-related disorders and suicide risk that can inform personalized treatment approaches. By identifying reliable neurobehavioral markers of risk and treatment response, this work aims to improve the precision, accessibility and effectiveness of interventions for individuals with psychiatric disorders.
I have contributed to peer-reviewed publications in journals including Biological Psychiatry, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, NeuroImage, JAMA Network Open, Behavior Therapy, Psychological Assessment and the journal Psychotherapy and Psychosomatics.
TP240198 - “Examining the Efficacy of Short-Term Intensive PTSD Treatment on Psychological and Cognitive Impairment Symptoms” - FY24 DoD TBIPHRP Health Services Research Award - Clinical Trial
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 11/3/2025, Jaryd Hiser has reported no relationships with companies or entities.